Skip to content

Content Library


Welcome to Tigerlily Foundation’s Clinical Trials Content Library, your comprehensive resource for exploring the latest advancements in breast cancer research and treatment options. We understand that the journey through breast cancer can be overwhelming, but we believe that knowledge is power. Our curated collection of informative and accessible content aims to provide you with the necessary tools to make informed decisions about your health. Discover a wealth of information on clinical trials, empowering you to navigate through the complexities of metastatic breast cancer and find renewed hope. Together, we can conquer this disease and pave the way for a brighter future.

‘From Molecules to More Moments’ Video Series

Tigerlily Foundation’s ‘From Molecules to More Moments’ campaign builds trust and transparency by providing a lens to understand the individuals behind clinical trials and the people whose lives clinical trials affect. Clinical trials are really about innovation, revolutionary ways of thinking, dedication, and developing therapies – beginning with a molecule – that equates to more moments in life.

Tiger Talk Blog Series

Review our conversations and insights surrounding clinical trials and the clinical trial experience through our coming blog series, Tiger Talk.

Clinical Trials 101 Infographic

Review a bite-sized, easily digestible summary of key information helpful in understanding the how and why behind clinical trials.

Understanding Clinical Trials

This guide helps empower readers by providing information about clinical trials in a thorough, reader-friendly format. You are the expert on you! If you are going to make an informed decision about your care plan and whether or not to include a trial as part of that plan, it’s important that you have time, space, and resources to help you understand that decision.

Novartis’ Metastatic Breast Cancer Patient Glossary

Review a short list of key terminology from Novartis that you might encounter when reading about or considering metastatic breast cancer clinical trials.